-
Prevalence of inflammatory bowel disease: estimates for 2010 and trends in Ge...
Objective. A worldwide increase in prevalence of inflammatory bowel disease (IBD) has been reported. For Germany, latest publications not restricted to actively treated disease... -
Impact of ulcerative colitis on patients’ lives: results of the Finnish exten...
Introduction: The Ulcerative Colitis (UC) Narrative is a global initiative to engage patients with UC, in order to help identify the impact of UC on patients’ lives. The aim of... -
Patients with liver cirrhosis show worse survival if decompensation occurs la...
Objectives: Liver cirrhosis is characterized by a silent phase until decompensation, which is defined by onset of ascites, variceal bleeding, or encephalopathy. Although it is... -
Long-term evolution of direct healthcare costs for inflammatory bowel disease...
Introduction: We explored the long-term evolution of direct healthcare costs for inflammatory bowel diseases (IBD) using a population-level database in a country with an... -
dedup_wf_001--ce8f52f6f2a8d292a7d5d39d531c12d5
Objectives: Faecal Calprotectin (FC) is a sensitive marker for gut inflammation. However, slightly elevated FC levels are also common in subjects without inflammation. We... -
dedup_wf_001--c6a6858181eec62570dd5536a1491a63
Background/aim: The objective of this study is to identify clinical predictors of primary non-response (PNR) and secondary loss of response (LOR), in Crohn’s disease (CD)... -
Liver transplantation for acute liver failure – a 30-year single center exper...
Objective: To determine overall long-term patient and graft survival rates among the recipients liver transplanted due to acute liver failure (ALF). Secondary aims included... -
Surgical treatment for gallbladder cancer – a systematic literature review
Objective: To evaluate existing evidence regarding surgical treatments for gallbladder cancer in a Health Technology Assessment. A specific aim was to evaluate whether extended... -
Treatment for occult hepatocellular carcinoma: does it offer survival advanta...
OBJECTIVE: In order to claim a benefit of screen-based diagnosis for asymptomatic individuals, treatment of occult disease needs to offer survival advantages compared to the... -
Efficacy and safety of submucosal tunneling endoscopic resection for upper ga...
Objectives: Submucosal tunneling endoscopic resection (STER) is a novel therapeutic approach for upper gastrointestinal submucosal tumors (SMTs) especially for tumors... -
Indirect comparison of vedolizumab and adalimumab for biologic-naive patients...
Aim: Indirect comparison of efficacy and safety of vedolizumab with adalimumab in biologic-naïve patients with moderate to severe ulcerative colitis (UC). Methods: Vedolizumab... -
The adherence to the therapy in inflammatory bowel disease: beyond the number...
Objectives: The therapy of the inflammatory bowel diseases is quite complex. A partial compliance increases the relapse probability and the health expenditure. The aim of the... -
Biliary tract malignancies: a population-based study on incidence, prognosis ...
Background: Biliary tract malignancies are uncommon and few population-based studies are available. Methods: This nationwide population-based study in Iceland included all... -
Intestinal parasitic infections in different groups of immunocompromised pati...
Introduction: Intestinal parasitic infections (IPIs) are important causes of morbidity and mortality in patients with immunocompromising conditions. Objective: The aim of this... -
Somatostatin analogue-induced pancreatic exocrine insufficiency in patients w...
Background: Patients with advanced well-differentiated neuroendocrine tumours (Wd-NETs) are commonly treated with somatostatin analogues (SSAs). Some patients may develop... -
Cancer risk and chemoprevention in Chinese inflammatory bowel disease patient...
Background and aim: Role of 5-aminosalicylic acid (5-ASA), statin and aspirin in reducing cancer risks in inflammatory bowel disease (IBD) remains controversial. We aimed to... -
Different pattern of risk factors for post-ERCP pancreatitis in patients with...
Objective: To identify possible risk factors associated with post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) in biliary stricture (BS), common bile... -
Safety and tolerability of linaclotide for the treatment of chronic idiopathi...
Background: Linaclotide is approved for treating irritable bowel syndrome with constipation (IBS-C; 290 µg QD) and chronic idiopathic constipation (CIC; 145 µg or 72 µg QD)....
